Mast Therapeutics (MSTX) Stock Trending Up On New Agreement Announcement

Mast Therapeutics Inc (NYSEMKT: MSTX) Mast Therapeutics has had a rough time in the market as of late. After announcing recently that a Phase 3 clinical trial looking into a sickle cell treatment had failed, the stock took a dive. However, things seem to be changing direction today. Early this morning, the company released a … Read more

Mast Therapeutics (MSTX) Stock: EPIC Primary Endpoint Missed!

Update 9/20/2016 2:12 Primary Endpoint Missed A press release was just offered showing that MSTX missed its primary endpoint in the clinical study discussed in this post. In response, Brian M. Culley, Mast Therapeutics CEO, had the following to offer: “We are exceedingly disappointed with these top-line results. While clearly not the outcome we wanted, … Read more

Mast Therapeutics (MSTX) Stock: Worried About Declines? What You Should Know!

Mast Therapeutics Inc (NYSEMKT: MSTX) Mast Therapeutics had an incredible month in August. In the beginning of September, we saw more of the same. However, more recently, we’ve been seeing declines on the stock. Now investors are starting to ask, “Should I be worried?” The truth is that, while the stock has incredible upside potential, … Read more

Mast Therapeutics (MSTX) Stock: The Full Story You Need To Know

Mast Therapeutics Inc (NYSEMKT: MSTX) Mast Therapeutics has been an incredible stock to follow as of late, and for good reason. The stock has gained considerably recently. But what’s causing the gains? What are the risks? What’s the full story? Today, I’ll do my best to explain everything. What’s Causing The Gains On MSTX? With … Read more